Christopher K. Mehta
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Christopher K. Mehta has a total of 121 co-authors. Here are the top co-authors by number of shared publications:
Beth Whippo
10 shared publicationsDuc Thinh Pham
7 shared publicationsDouglas R. Johnston
Division of Cardiac Surgery, Northwestern University Feinberg School of Medicine and Bluhm Cardiovascular Institute, Northwestern Medicine, Chicago, IL
6 shared publicationsS. Chris Malaisrie
6 shared publications- Sukit Christopher Malaisrie
Northwestern University Feinberg School of Medicine
6 shared publications Patrick M. McCarthy
5 shared publications
Latest Publications
- Open Access
- 27 June 2026
- Published by Elsevier in Annals of Thoracic Surgery Short Reports
Combined Transapical Aortic and Mitral Transcatheter Valve Replacement
- 27 June 2026
- Published by Elsevier in Annals of Thoracic Surgery Short Reports
Open AccessCombined Transapical Aortic and Mitral Transcatheter Valve Replacement
- 16 April 2026
- Published by SAGE Publications in Asian Cardiovascular and Thoracic Annals
- Vol. 34 (4) , 329-337
A modified David V: Technique and outcomes from a large single centre experience
Introduction: Replacement of the aortic root with a composite valve-graft and coronary reimplantation is the most widely performed operation for patients requiring aortic root replacement; however valve sparing operations have been developed to preserve the aortic valve in certain populations. Since they were first introduced, the remodeling and reimplantation techniques have undergone many refinements and modifications. We describe the technical steps and outcomes of a modified David V procedure, adapted from the Stanford modification, performed at our institution. Methods: Between November 2007 and March 2025, 417 patients underwent valve-sparing aortic root replacement at our institution. Of those, 185 patients underwent an adapted Stanford modification of valve-sparing aortic root replacement. A retrospective review of these patients was performed from a prospectively maintained institutional database. Results: Mean age was 47.6 ± 15.7 years and 81% were male. About 20.5% of patients had a heritable thoracic aortic disorder and 22.1% had a bicuspid aortic valve. The technique of our modified David V procedure is described. There was one post-operative mortality (0.5%) and no 30-day reinterventions. Early postoperative echocardiographic follow-up within 90 days was available in 91% of patients ( n = 168), with no cases of greater than moderate aortic insufficiency. Survival at 1, 5, and 10 years was 99%, 98%, and 92%, respectively. Freedom from aortic valve or aortic re-operation at 1, 5, and 10 years was 99%, 97%,and 94%, respectively. Conclusion: While the specific type and size of graft used in valve-sparing aortic root replacement appears to matter less than meticulous technique and valve assessment, our series of 185 patients undergoing a modified David V procedure shows favorable early and midterm results.
- 16 April 2026
- Published by SAGE Publications in Asian Cardiovascular and Thoracic Annals
- Vol. 34 (4) , 329-337
A modified David V: Technique and outcomes from a large single centre experience
Introduction: Replacement of the aortic root with a composite valve-graft and coronary reimplantation is the most widely performed operation for patients requiring aortic root replacement; however valve sparing operations have been developed to preserve the aortic valve in certain populations. Since they were first introduced, the remodeling and reimplantation techniques have undergone many refinements and modifications. We describe the technical steps and outcomes of a modified David V procedure, adapted from the Stanford modification, performed at our institution. Methods: Between November 2007 and March 2025, 417 patients underwent valve-sparing aortic root replacement at our institution. Of those, 185 patients underwent an adapted Stanford modification of valve-sparing aortic root replacement. A retrospective review of these patients was performed from a prospectively maintained institutional database. Results: Mean age was 47.6 ± 15.7 years and 81% were male. About 20.5% of patients had a heritable thoracic aortic disorder and 22.1% had a bicuspid aortic valve. The technique of our modified David V procedure is described. There was one post-operative mortality (0.5%) and no 30-day reinterventions. Early postoperative echocardiographic follow-up within 90 days was available in 91% of patients ( n = 168), with no cases of greater than moderate aortic insufficiency. Survival at 1, 5, and 10 years was 99%, 98%, and 92%, respectively. Freedom from aortic valve or aortic re-operation at 1, 5, and 10 years was 99%, 97%,and 94%, respectively. Conclusion: While the specific type and size of graft used in valve-sparing aortic root replacement appears to matter less than meticulous technique and valve assessment, our series of 185 patients undergoing a modified David V procedure shows favorable early and midterm results.
- 13 April 2026
- Published by SAGE Publications in Asian Cardiovascular and Thoracic Annals
- Vol. 34 (4) , 346-354
Ross procedure: Evidence for pulmonary autograft and early outcomes
Background: Renewed interest in the Ross procedure in young adults has been tempered by questions over safety and early outcomes. This paper examines our institution's 1-year outcomes of the Ross procedure. Methods: From November 2019 to February 2025, 136 consecutive adult patients underwent a Ross procedure at an urban tertiary center. The first 50 patients had follow-up beyond 1 year and constitute the study group of this case series. Results: Median age was 41 years (IQR: 30, 47). The majority were male ( n = 34, 68%). The most common indication for surgery was aortic stenosis with or without aortic regurgitation (AR) ( n = 34, 68%), followed by pure AR ( n = 14, 28%), then aortic aneurysm with valve dysfunction ( n = 2, 4%). Valve morphology was bicuspid in 22 (44%) patients, unicuspid in 21 (42%), and tricuspid in 5 (10%). Primary etiology was congenital in 42 (84%) patients, degenerative in 2 (4%), failed mechanical valve in 2 (4%), healed endocarditis in 1 (2%), rheumatic disease in 1 (2%), radiation-induced in 1 (2%), and unknown in 1 (2%). Redo sternotomy was performed in 2 (4%) patients, ascending aorta replacement in 43 (86%), hemiarch replacement in 22 (44%), and external aortic annuloplasty ring in 23 (46%). In-hospital and 30-day mortality was 0%, with 2 (4%) permanent strokes post-operatively but with no or minimal residual deficits. There was 1 mortality at 1.1 years, 1 autograft re-intervention at 1.8 years, 1 autograft re-intervention at 4.1 years, and 1 homograft re-intervention at 2.7 years. Conclusion: This paper demonstrates early safety of the Ross procedure for adults. More longitudinal data is needed to determine long-term efficacy and durability.
- 13 April 2026
- Published by SAGE Publications in Asian Cardiovascular and Thoracic Annals
- Vol. 34 (4) , 346-354
Ross procedure: Evidence for pulmonary autograft and early outcomes
Background: Renewed interest in the Ross procedure in young adults has been tempered by questions over safety and early outcomes. This paper examines our institution's 1-year outcomes of the Ross procedure. Methods: From November 2019 to February 2025, 136 consecutive adult patients underwent a Ross procedure at an urban tertiary center. The first 50 patients had follow-up beyond 1 year and constitute the study group of this case series. Results: Median age was 41 years (IQR: 30, 47). The majority were male ( n = 34, 68%). The most common indication for surgery was aortic stenosis with or without aortic regurgitation (AR) ( n = 34, 68%), followed by pure AR ( n = 14, 28%), then aortic aneurysm with valve dysfunction ( n = 2, 4%). Valve morphology was bicuspid in 22 (44%) patients, unicuspid in 21 (42%), and tricuspid in 5 (10%). Primary etiology was congenital in 42 (84%) patients, degenerative in 2 (4%), failed mechanical valve in 2 (4%), healed endocarditis in 1 (2%), rheumatic disease in 1 (2%), radiation-induced in 1 (2%), and unknown in 1 (2%). Redo sternotomy was performed in 2 (4%) patients, ascending aorta replacement in 43 (86%), hemiarch replacement in 22 (44%), and external aortic annuloplasty ring in 23 (46%). In-hospital and 30-day mortality was 0%, with 2 (4%) permanent strokes post-operatively but with no or minimal residual deficits. There was 1 mortality at 1.1 years, 1 autograft re-intervention at 1.8 years, 1 autograft re-intervention at 4.1 years, and 1 homograft re-intervention at 2.7 years. Conclusion: This paper demonstrates early safety of the Ross procedure for adults. More longitudinal data is needed to determine long-term efficacy and durability.
- Open Access
- 7 January 2026
- Published by Elsevier in Journal of Vascular Surgery Cases, Innovations and Techniques
- Vol. 12 (2) , 102140
Complex aortic reconstruction using double-barrel frozen elephant trunks
- 7 January 2026
- Published by Elsevier in Journal of Vascular Surgery Cases, Innovations and Techniques
- Vol. 12 (2) , 102140
Open AccessComplex aortic reconstruction using double-barrel frozen elephant trunks
- Open Access
- 4 October 2025
- Published by Elsevier in JTCVS Open
- Vol. 28, 349-357
Association of mild-to-moderate Model for End-Stage Liver Disease scores on short-term cardiac surgery postoperative outcomes
- 4 October 2025
- Published by Elsevier in JTCVS Open
- Vol. 28, 349-357
Open AccessAssociation of mild-to-moderate Model for End-Stage Liver Disease scores on short-term cardiac surgery postoperative outcomes
- 25 September 2025
- Published by SAGE Publications in Asian Cardiovascular and Thoracic Annals
- Vol. 33 (8-9) , 275-280
Short-term outcomes in upper-hemi sternotomy for ascending and hemi-arch aortic repair with and without concomitant aortic valve replacement or repair
Introduction: Full median sternotomy is the traditional operative approach for ascending aortic aneurysm repair. Minimally invasive approaches are being used more frequently by surgeons to enhance recovery. Methods: This is a single-institution, multi-surgeon retrospective review of adult patients who underwent elective aneurysm surgery involving the ascending aorta and proximal arch between 1 January 2015 and 30 June 2024 with and without aortic valve replacement/repair. Exclusion criteria included re-operation, aortic root procedure, and other concomitant valve procedure or coronary artery bypass grafting. Operative and short-term clinical outcomes were compared between patients undergoing upper hemi-sternotomy (UHS) and full median sternotomy (FMS). Results: Among 166 patients in the analysis dataset, 84 (50.6%) underwent FMS and 82 (49.4%) underwent UHS. UHS and FMS groups had similar median cardiopulmonary bypass time (129 vs. 137 min, p = 0.436) and median aortic cross-clamp time (92 vs. 96.5 min, p = 0.900). Patients undergoing UHS were more likely to be discharged home (93.9% vs. 83.3%, p = 0.032) and had a shorter length of stay (5 vs. 6 days, p < 0.001) compared to FMS. 30-day mortality occurred in one patient (1.2%) in the FMS group. Conclusions: Elective aneurysm repair can be performed safely with less invasive hemi-sternotomy approaches. Minimally invasive approaches enhance recovery after surgery. Future prospective studies are needed to clarify potential benefits in postoperative pain and quality of life.
- 25 September 2025
- Published by SAGE Publications in Asian Cardiovascular and Thoracic Annals
- Vol. 33 (8-9) , 275-280
Short-term outcomes in upper-hemi sternotomy for ascending and hemi-arch aortic repair with and without concomitant aortic valve replacement or repair
Introduction: Full median sternotomy is the traditional operative approach for ascending aortic aneurysm repair. Minimally invasive approaches are being used more frequently by surgeons to enhance recovery. Methods: This is a single-institution, multi-surgeon retrospective review of adult patients who underwent elective aneurysm surgery involving the ascending aorta and proximal arch between 1 January 2015 and 30 June 2024 with and without aortic valve replacement/repair. Exclusion criteria included re-operation, aortic root procedure, and other concomitant valve procedure or coronary artery bypass grafting. Operative and short-term clinical outcomes were compared between patients undergoing upper hemi-sternotomy (UHS) and full median sternotomy (FMS). Results: Among 166 patients in the analysis dataset, 84 (50.6%) underwent FMS and 82 (49.4%) underwent UHS. UHS and FMS groups had similar median cardiopulmonary bypass time (129 vs. 137 min, p = 0.436) and median aortic cross-clamp time (92 vs. 96.5 min, p = 0.900). Patients undergoing UHS were more likely to be discharged home (93.9% vs. 83.3%, p = 0.032) and had a shorter length of stay (5 vs. 6 days, p < 0.001) compared to FMS. 30-day mortality occurred in one patient (1.2%) in the FMS group. Conclusions: Elective aneurysm repair can be performed safely with less invasive hemi-sternotomy approaches. Minimally invasive approaches enhance recovery after surgery. Future prospective studies are needed to clarify potential benefits in postoperative pain and quality of life.
- 2 July 2025
- Published by Elsevier in The Annals of Thoracic Surgery
- Vol. 120 (5) , 832-841
Surgical Outcomes of Iatrogenic Acute Type A Aortic Dissection During Catheter-Based Procedures: An STS Cardiac Surgery Database Analysis
- 2 July 2025
- Published by Elsevier in The Annals of Thoracic Surgery
- Vol. 120 (5) , 832-841
Surgical Outcomes of Iatrogenic Acute Type A Aortic Dissection During Catheter-Based Procedures: An STS Cardiac Surgery Database Analysis
- Open Access
- 20 June 2025
- Published by Elsevier in JTCVS Open
- Vol. 26, 52-60
Concomitant atrial fibrillation ablation during aortic valve and aneurysm surgery
- 20 June 2025
- Published by Elsevier in JTCVS Open
- Vol. 26, 52-60
Open AccessConcomitant atrial fibrillation ablation during aortic valve and aneurysm surgery
- Open Access
- 14 December 2024
- Published by Elsevier in JTCVS Structural and Endovascular
- Vol. 5
Restoration of 3-dimensional aortic hemodynamics after the Ross procedure for unicuspid aortic valve disease using 4-dimensional flow magnetic resonance imaging
- 14 December 2024
- Published by Elsevier in JTCVS Structural and Endovascular
- Vol. 5
Open AccessRestoration of 3-dimensional aortic hemodynamics after the Ross procedure for unicuspid aortic valve disease using 4-dimensional flow magnetic resonance imaging